Oxford Nanopore Technologies plc (LON:ONT)
London
· Delayed Price · Currency is GBP · Price in GBp | Market Cap | 2.11B |
| Revenue (ttm) | 183.19M |
| Net Income (ttm) | -146.19M |
| Shares Out | 962.18M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,316,631 |
| Average Volume | 3,420,195 |
| Open | 222.00 |
| Previous Close | 219.00 |
| Day's Range | 210.80 - 222.40 |
| 52-Week Range | 88.60 - 224.80 |
| Beta | 0.90 |
| RSI | 68.01 |
| Earnings Date | Sep 1, 2025 |
About LON:ONT
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its cu... [Read more]
Financial Performance
In 2024, LON:ONT's revenue was 183.19 million, an increase of 7.97% compared to the previous year's 169.67 million. Losses were -146.19 million, -5.38% less than in 2023.
Financial StatementsNews
ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology
OXFORD, England & VIENNA, Austria--(BUSINESS WIRE)-- #Lifesciences--ViruSure, a global leader in pathogen safety testing for biopharmaceuticals, and Oxford Nanopore Technologies (“Oxford Nanopore”) (L...
FTSE 100 Breaks 9,000 as Miners Surge
FTSE 100 tops 9,000 as miners surge on China demand; Oxford Nanopore shines, Verici slides. The post FTSE 100 Breaks 9,000 as Miners Surge appeared first on Investomania .
Breakthrough algorithm enables partially phased, near telomere-to-telomere assembly using standard Oxford Nanopore Simplex reads
OXFORD, England--(BUSINESS WIRE)-- #Nanopore--A new paper, released this week on bioRxiv, introduces hifiasm-ONT, a breakthrough genome assembly algorithm that enables partially phased, near telomere-...
Oxford Nanopore Expands Compatible Products Programme and Strengthens Multi-Omics Ecosystem
OXFORD, England--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose pr...
Oxford Nanopore Technologies plc (ONTTF) Q4 2024 Earnings Call Transcript
UK Stock Market News: Greggs, Beazley, Oxford Nanopore
Greggs on a roll as divi up and staff share £20m payout, record profits at Beazley, steady progress as Oxford Nanopore look to mid-term goals
UK Stock Market News: PageGroup, Oxford Nanopore, Entain
PageGroup: no signs of recovery in recruitment, Oxford Nanopore gross margin outlook upped, Entain bets on "operator friendly" Q4
Oxford Nanopore and UK Biobank to create world's first epigenetic dataset targeting the causes of cancer, dementia, complex disease
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK Biob...
UK health agencies join with Oxford Nanopore to speed up pathogen screening
Initiative is part of growing international efforts to give early warning of pandemic threats
Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a landmark strategic partnership with the UK ...
Half Year 2024 Oxford Nanopore Technologies PLC Earnings Presentation Transcript
Half Year 2024 Oxford Nanopore Technologies PLC Earnings Presentation Transcript
Oxford Nanopore reports 1H results
Read about Oxford Nanopore's 1H revenue decline but reiterated full-year guidance, with an adjusted EBITDA loss due to rising operational expenses.
Oxford Nanopore Eyes FTSE 250 Inclusion to Widen Investor Base
Oxford Nanopore Technologies Plc, the DNA-sequencing firm whose shares have plunged since going public, is setting its sights on FTSE 250 index inclusion that would widen the pool of potential investo...
Oxford Nanopore Technologies plc (ONTTF) Q2 2024 Earnings Call Transcript
Oxford Nanopore Technologies plc 2024 Q2 - Results - Earnings Call Presentation
The following slide deck was published by Oxford Nanopore Technologies plc in conjunction with their 2024 Q2 earnings call.
Oxford Nanopore Technologies and Plasmidsaurus Announce Strategic Collaboration to Advance Plasmid Sequencing
OXFORD, England, & LOS ANGELES--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, th...
Oxford Nanopore Technologies (ONT) - Product Pipeline Analysis 2024
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Oxford Nanopore Technologies Plc (ONT) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. Oxf...
RenovaroCube to acquire 100% ownership of Cyclomics
Renovaro strengthens its position in cancer diagnostics with the acquisition of Cyclomics, leveraging their partnerships with Oxford Nanopore and Nvidia.
Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and SeqOne, the leading AI...
Oxford Nanopore launches PromethION 2 Integrated into open early access
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i) to complete its P...
Oxford Nanopore Technologies plc (ONTTF) Full Year 2023 Earnings Call Transcript
Oxford Nanopore GAAP EPS of $19.00p, revenue of £169.7M
Oxford Nanopore: Ultra-Long Reads In A Short-Term Slump
Oxford Nanopore shares declined 33% due to slower growth, but positive prospects and unique product features offer potential. See more on ONTTF stock here.
Britain's Oxford Nanopore's shares sink after revenue warning
Shares in Britain's Oxford Nanopore dropped nearly 12% on Tuesday, after the sensing technology company issued a revenue warning, citing a slowdown in China and the Middle East, along with staggered p...
Oxford Nanopore sales hit by US semiconductor restrictions
Oxford Nanopore Technologies said it had seen disruption to its diagnostics businesses due to the US/China trade war and second-half sales growth was slower than expected in some areas Over 2023, rev...